These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30595045)

  • 1. Detecting Adverse Drug Events: Accuracy and Generalizability.
    Walter SR; Gallego B
    Ther Innov Regul Sci; 2019 Nov; 53(6):795-796. PubMed ID: 30595045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Authenticity and credibility aware detection of adverse drug events from social media.
    Hoang T; Liu J; Pratt N; Zheng VW; Chang KC; Roughead E; Li J
    Int J Med Inform; 2018 Dec; 120():101-115. PubMed ID: 30409335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Authenticity and credibility aware detection of adverse drug events from social media.
    Hoang T; Liu J; Pratt N; Zheng VW; Chang KC; Roughead E; Li J
    Int J Med Inform; 2018 Dec; 120():157-171. PubMed ID: 30409341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug event detection in pediatric oncology and hematology patients: using medication triggers to identify patient harm in a specialized pediatric patient population.
    Call RJ; Burlison JD; Robertson JJ; Scott JR; Baker DK; Rossi MG; Howard SC; Hoffman JM
    J Pediatr; 2014 Sep; 165(3):447-52.e4. PubMed ID: 24768254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review.
    Luo Y; Thompson WK; Herr TM; Zeng Z; Berendsen MA; Jonnalagadda SR; Carson MB; Starren J
    Drug Saf; 2017 Nov; 40(11):1075-1089. PubMed ID: 28643174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of adverse drug event information in US manufacturer labels.
    Harrington CA; Garcia AS; Sircar-Ramsewak F
    Curr Drug Saf; 2011 Feb; 6(1):30-5. PubMed ID: 21047299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
    Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
    Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Drug Events Detection in Clinical Notes by Jointly Modeling Entities and Relations Using Neural Networks.
    Dandala B; Joopudi V; Devarakonda M
    Drug Saf; 2019 Jan; 42(1):135-146. PubMed ID: 30649738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a computer-based adverse-drug-event monitor.
    Hwang SH; Lee S; Koo HK; Kim Y
    Am J Health Syst Pharm; 2008 Dec; 65(23):2265-72. PubMed ID: 19020194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine use of the "ADE scorecards", an application for automated ADE detection in a general hospital.
    Chazard E; Luyckx M; Beuscart JB; Ferret L; Beuscart R
    Stud Health Technol Inform; 2013; 192():308-12. PubMed ID: 23920566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Medication-Related Adverse Drug Events in Nursing Facilities in East Texas.
    Tenhunen ML; Smithers B; Tucker B
    Consult Pharm; 2016; 31(8):436-9. PubMed ID: 27535078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review to evaluate the accuracy of electronic adverse drug event detection.
    Forster AJ; Jennings A; Chow C; Leeder C; van Walraven C
    J Am Med Inform Assoc; 2012; 19(1):31-8. PubMed ID: 22155974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting potential signals of adverse drug events from prescription data.
    Zhan C; Roughead E; Liu L; Pratt N; Li J
    Artif Intell Med; 2020 Apr; 104():101839. PubMed ID: 32499007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From adverse drug event detection to prevention. A novel clinical decision support framework for medication safety.
    Koutkias VG; McNair P; Kilintzis V; Skovhus Andersen K; Niès J; Sarfati JC; Ammenwerth E; Chazard E; Jensen S; Beuscart R; Maglaveras N
    Methods Inf Med; 2014; 53(6):482-92. PubMed ID: 25377477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach.
    Mirbaha F; Shalviri G; Yazdizadeh B; Gholami K; Majdzadeh R
    Implement Sci; 2015 Aug; 10():110. PubMed ID: 26250159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.
    Hébert G; Netzer F; Kouakou SL; Lemare F; Minvielle E;
    Int J Clin Pharm; 2018 Apr; 40(2):376-385. PubMed ID: 29446003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the black triangle scheme and its online educational campaign on the quantity and quality of adverse drug event reporting in Australia: a time series analysis.
    Li R; Curtis K; Zaidi STR; Van C; Castelino R
    Expert Opin Drug Saf; 2020 Jun; 19(6):747-753. PubMed ID: 32207361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSEL-ADE: A semi-supervised ensemble learning framework for extracting adverse drug events from social media.
    Liu J; Zhao S; Wang G
    Artif Intell Med; 2018 Jan; 84():34-49. PubMed ID: 29111222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records.
    Liu F; Jagannatha A; Yu H
    Drug Saf; 2019 Jan; 42(1):95-97. PubMed ID: 30649734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.